Axsome Therapeutics Inc.
(AXSM) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
84.62
-0.63%
Pre-market Jan 07, 2025, 06:03 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 386.19M | 200.84M | 86.47M | 183.88M | 219.97M | 13.97M | 34.02M | 36.62M | 48.04M | 2.62M | 2.09M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 11.03M | 14.72M | 322.91K | 317.38K | 139.88K | 112.34K | 187.95K | 112.82K | 26.63K | 42.62K | n/a |
Receivables | 94.82M | 37.70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 15.13M | 4.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.12M | 5.56M | 45.29K | 148.37K | 413.10K | 1.25M | 1.28M | 1.38M | 1.99M | 125.94K | 9.53K |
Total Current Assets | 504.26M | 245.64M | 86.52M | 184.02M | 220.38M | 15.22M | 35.30M | 38.00M | 49.03M | 2.74M | 2.10M |
Property-Plant & Equipment | 7.62M | 1.14M | 944.01K | 1.79M | 30.62K | 51.83K | 68.07K | 100.73K | 16.65K | n/a | n/a |
Goodwill & Intangibles | 65.33M | 69.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 83.97M | 85.83M | 1.27M | 2.11M | 170.50K | 164.18K | 256.02K | 213.55K | 43.28K | 42.62K | n/a |
Total Assets | 588.24M | 331.48M | -338.36M | 186.13M | 220.55M | 15.38M | 35.56M | 38.21M | 49.08M | 2.79M | 2.10M |
Account Payables | 40.68M | 38.60M | 13.15M | 13.50M | 10.94M | 3.69M | 3.44M | 4.08M | 1.89M | 758.16K | 159.32K |
Deferred Revenue | n/a | n/a | n/a | n/a | 10.27M | 3.32M | 2.35M | 2.23M | n/a | 36.45K | n/a |
Short-Term Debt | 1.27M | 425.00K | 620.67K | 1.22M | 2.60M | 3.29M | 3.27M | 269.16K | n/a | 41.47K | 3.83M |
Other Current Liabilities | 96.91M | 57.53M | 9.30M | 8.71M | 10.95M | 3.84M | 5.47M | 2.82M | 739.53K | 172.99K | 140.17K |
Total Current Liabilities | 138.85M | 96.56M | 23.07M | 23.44M | 24.49M | 10.82M | 12.18M | 7.17M | 2.63M | 972.62K | 4.13M |
Long-Term Debt | 185.10M | 94.26M | 49.09M | 48.90M | 17.33M | 3.62M | 6.66M | 9.47M | n/a | 4.44M | n/a |
Other Long-Term Liabilities | 73.30M | 31.10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 574.92K | n/a |
Total Long-Term Liabilities | 258.40M | 125.36M | 49.09M | 48.90M | 17.33M | 3.62M | 6.66M | 9.47M | n/a | 5.02M | n/a |
Total Liabilities | 397.26M | 221.92M | 70.84M | 72.34M | 41.83M | 14.44M | 18.84M | 16.64M | 2.63M | 5.99M | 4.13M |
Total Debt | 186.37M | 94.68M | 49.71M | 50.12M | 19.93M | 6.91M | 9.93M | 9.74M | n/a | 4.48M | 3.83M |
Common Stock | 5.00K | 4.35K | 3.78K | 3.74K | 3.69K | 3.01K | 2.55K | 1.92K | 1.92K | 1.11K | 769.00 |
Retained Earnings | -835.57M | -596.33M | -409.20M | -278.80M | -175.90M | -107.55M | -76.58M | -47.64M | -18.79M | -8.23M | -2.23M |
Comprehensive Income | 0.00 | n/a | 0.00 | n/a | -0.00 | n/a | 0.00 | n/a | 0.00 | n/a | -5.10K |
Shareholders Equity | 190.98M | 109.56M | -409.20M | -278.80M | -175.90M | -107.55M | -76.58M | -47.64M | -18.79M | -3.20M | -2.03M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |